These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16216595)

  • 1. Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease.
    Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
    Atherosclerosis; 2005 Nov; 183(1):157-62. PubMed ID: 16216595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.
    Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):204-9. PubMed ID: 10634819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.
    Wu R; Nityanand S; Berglund L; Lithell H; Holm G; Lefvert AK
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3159-63. PubMed ID: 9409306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
    Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
    Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
    McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
    N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty.
    George J; Harats D; Bakshi E; Adler Y; Levy Y; Gilburd B; Shoenfeld Y
    Immunol Lett; 1999 Jun; 68(2-3):263-6. PubMed ID: 10424430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
    Palosuo T; Virtamo J; Haukka J; Taylor PR; Aho K; Puurunen M; Vaarala O
    Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men.
    Vaarala O; Mänttäri M; Manninen V; Tenkanen L; Puurunen M; Aho K; Palosuo T
    Circulation; 1995 Jan; 91(1):23-7. PubMed ID: 7805207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
    Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies.
    Sherer Y; Tenenbaum A; Praprotnik S; Shemesh J; Blank M; Fisman EZ; Harats D; George J; Levy Y; Peter JB; Motro M; Shoenfeld Y
    Cardiology; 2001; 95(1):20-4. PubMed ID: 11385187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease.
    Luoma JS; Kareinen A; Närvänen O; Viitanen L; Laakso M; Ylä-Herttuala S
    Free Radic Biol Med; 2005 Dec; 39(12):1660-5. PubMed ID: 16298691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
    Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
    Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes.
    Oliveira JA; Sevanian A; Rodrigues RJ; Apolinário E; Abdalla DS
    Clin Biochem; 2006 Jul; 39(7):708-14. PubMed ID: 16782081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study.
    Wilson PW; Ben-Yehuda O; McNamara J; Massaro J; Witztum J; Reaven PD
    Atherosclerosis; 2006 Dec; 189(2):364-8. PubMed ID: 16476434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.